Note: Ingredients listed on restricted chemical lists
EC/CAS
137-58-6
Name of the chemical
Lidocaine (INN)
Concentration
2%
EC/CAS
99-76-3
Name of the chemical
4-hydroxybenzoic acid, methyl ester
Concentration
<1%
EC/CAS
94-13-3
Name of the chemical
Propylparaben; propyl 4-hydroxybenzoate
Concentration
<1%
EC/CAS
9004-65-3
Name of the chemical
methylhydroxypropylcellulose
Concentration
<3%
EC/CAS
7647-01-0
Name of the chemical
Hydrochloric acid
Concentration
N/A
EC/CAS
1310-73-2
Name of the chemical
sodium hydroxide
Concentration
N/A
General Information
Product name
Lidocaine Hydrochloride Jelly, USP 2%
Chemical name
Acetamide, 2-(diethylamino)-N-(2,6-dimethylphenyl)-, monohydrochloride C14H22N2O∙HCl Prescription Only
Manufacturer Name
Akorn
Icons in SDS
Company Information
company name
Akorn
e-mail address of the competent person responsible for the Safety Data Sheet
customer.service@akorn.com
Section 2
SECTION 2: Hazards identification
Principle Routes of Exposure
Inhalation and skin and eye contact. Lidocaine is well absorbed through mucous membranes, from the gastrointestinal tract, and through damaged skin. Carcinogenicity: NTP: No IARC: No
